(S (NP (JJ Modern) (NNS bio-technologies)) (VP (VBP have) (VP (VBN produced) (NP (NP (DT a) (JJ vast) (NN amount)) (PP (IN of) (NP (JJ high-throughput) (NNS data)))) (SBAR (IN with) (S (NP (NP (DT the) (NN number)) (PP (IN of) (NP (NNS predictors)))) (ADJP (ADJP (RB far) (JJR greater)) (PP (IN than) (NP (DT the) (JJ sample) (NN size)))))))) (. .))
(S (SBAR (IN In) (NN order) (S (VP (TO to) (VP (VP (VB identify) (NP (ADJP (JJR more) (JJ novel)) (NNS biomarkers))) (CC and) (VP (VB understand) (NP (JJ biological) (NN mechanisms))))))) (, ,) (NP (NP (PRP it))) (VP (VBZ is) (ADJP (JJ vital)) (S (VP (TO to) (VP (VB detect) (NP (NP (NNS signals)) (VP (ADVP (RB weakly)) (VBN associated) (PP (IN with) (NP (NP (NNS outcomes)) (PP (IN among) (NP (JJ ultrahigh-dimensional) (NNS predictors))))))))))) (. .))
(S (ADVP (RB However)) (, ,) (NP (NP (VBG existing) (VBG screening) (NNS methods)) (, ,) (SBAR (WHNP (WDT which)) (S (ADVP (RB typically)) (VP (VBP ignore) (NP (NN correlation) (NN information))))) (, ,)) (VP (VBP are) (ADJP (JJ likely) (S (VP (TO to) (VP (VB miss) (NP (DT these) (JJ weak) (NNS signals))))))) (. .))
(S (PP (IN By) (S (VP (VBG incorporating) (NP (DT the) (JJ inter-feature) (NN dependence))))) (, ,) (NP (PRP we)) (VP (VBP propose) (NP (NP (DT a) (JJ covariance-insured) (NN screening) (NN methodology)) (SBAR (S (VP (TO to) (VP (VB identify) (NP (NP (NNS predictors)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (ADJP (ADJP (RB jointly) (JJ informative)) (CC but) (VP (ADVP (RB only) (RB marginally) (RB weakly)) (VBN associated) (PP (IN with) (NP (NNS outcomes))))))))))))))) (. .))
(S (NP (NP (DT The) (NN validity)) (PP (IN of) (NP (DT the) (NN method)))) (VP (VBZ is) (VP (VBN examined) (PP (IN via) (NP (NP (JJ extensive) (NNS simulations)) (CC and) (NP (JJ real) (NNS data) (NNS studies)))) (PP (IN for) (S (VP (VBG selecting) (NP (NP (JJ potential) (JJ genetic) (NNS factors)) (ADJP (VBN related) (PP (TO to) (NP (NP (DT the) (NN onset)) (PP (IN of) (NP (NN cancer)))))))))))) (. .))
